CrannMed is developing resorbable embolic particles and a custom delivery catheter for the treatment of Knee Osteoarthritis.
CrannMed has raised $14.8M in total funding. The most recent round was Grant. The last funding was announced in February 2026.
CrannMed's investors include European Innovation Council, EIC Accelerator, EIT Health.
CrannMed is headquartered in Dublin, Ireland.
CrannMed is developing resorbable embolic particles and a custom delivery catheter for the treatment of Knee Osteoarthritis.
CrannMed is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CrannMed — Funding & Investors." VCBacked, February 17, 2026, https://www.vcbacked.co/company/crannmed. Accessed July 20, 2026.
VCBacked. (2026). CrannMed — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/crannmed
{{cite web |title=CrannMed — Funding & Investors |url=https://www.vcbacked.co/company/crannmed |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated